Agenda

• Introduction by Moderators: Edward Soltesz, MD & Oussama Wazni, MD
• Case Presentation – Advanced Fellow: Eoin Donnellan, MD
• 2020 CONVERGE Clinical Trial Overview: Tyler Taigen, MD
• Determining Candidates for the Hybrid Convergent Procedure: Ayman Hussein, MD
• Cardiac Surgery Approaches to Surgical Treatment with Catheter Ablation: Hybrid Convergent Procedure: Edward Soltesz, MD
• Electrophysiology Approaches to Surgical Treatment with Catheter Ablation: Hybrid Convergent Procedure: Walid Saliba, MD
• External Perspective: Best Practices and Guide to Hybrid Convergent Procedures: Andre Gauri, MD, Spectrum Health
• Presenter Panel Discussion     

Learning Objectives:

• Describe the convergent procedure and appropriate patients.
• Discuss methods of hybrid surgical ablation procedures performed collaboratively by electrophysiologists and cardiac surgeons.
• Identify the causes of sub-optimal outcomes in atrial ablation.

Complete CME process to claim your credit ›

Target Audience

This online series is designed for physicians, allied health practitioners and students interested in complex cardiovascular and thoracic conditions.

Accreditation Statement

The Cleveland Clinic Foundation Center for Continuing Education is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.

The Cleveland Clinic Foundation Center for Continuing Education designates this enduring activity for a maximum of 1.0 AMA PRA Category 1 CreditTM. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Participants claiming CME credit from this activity may submit the credit hours to the American Osteopathic Association for Category 2 credit.

CME Disclaimer

The information in this educational activity is provided for general medical education purposes only and is not meant to substitute for the independent medical judgment of a physician relative to diagnostic and treatment options of a specific patient's medical condition. The viewpoints expressed in this CME activity are those of the authors/faculty. They do not represent an endorsement by The Cleveland Clinic Foundation. In no event will The Cleveland Clinic Foundation be liable for any decision made or action taken in reliance upon the information provided through this CME activity.

Faculty Disclosure

In accordance with the Standards for Commercial Support issued by the Accreditation Council for Continuing Medical Education (ACCME), The Cleveland Clinic Foundation Center for Continuing Education requires resolution of all faculty conflicts of interest to ensure CME activities are Free of commercial bias.

The following faculty has indicated they have no relationship which, in the context of their presentation(s), could be perceived as a potential conflict of interest: Oussama Wazni, MD, Eoin Donnellan, MD, Tyler L Taigen, MD, Andre Gauri, MD, Ayman Hussein, MD.

The following faculty has indicated that they may have a relationship, which in the context of their presentation(s) could be perceived as a potential conflict of interest: Eric E Roselli, MD, Activity Director: Abbott - Teaching and Speaking. Cook Medical - Teaching and Speaking. Cryolife, Inc. -Consulting. Edwards Lifesciences - Teaching and Speaking. LivaNova, PLC - Consulting, Teaching and Speaking. Medtronic - Consulting. Terumo - Teaching and Speaking. W.L. Gore & Associates - Consulting. Edward Soltesz, MD: Abbott Vascular - Teaching and Speaking. Abiomed - Teaching and Speaking. Edwards Lifesciences - Teaching and Speaking. Walid Saliba, MD: Boston Scientific - Membership on advisory committee or review panels.

For further information about this activity, contact Katie Breznai at [email protected]